Swarajya Logo
  • Morning Brief
  • States
  • Politics
  • Economy
  • Business
  • Culture
  • Infra
  • Defence
  • World
  • Books
  • Ideas
  • Science
  • Technology
  • Heritage
  • Archives
  • News Brief
  • Our Views
  • Magazine
  • Headlines
  • Store

antiviral drug

All You Need To Know About Merck’s Covid Pill That Cuts Risk Of Death And Hospitalisation By 50 Per Cent

Bhaswati Guha Majumder
3y News Brief
image

Remdesivir Production In India Increased Threefold To 1.05 Crore Vials Per Month: Union Minister Mansukh Mandaviya

Swarajya Staff
4y News Brief
image

Karnataka To Import 2 Lakh Vials Of Antiviral Drug Remdesivir To Treat COVID Patients

IANS
4y News Brief
image

Centre Takes Steps To Increase Antiviral Remdesivir Production From 38 Lakh Vials Per Month To 78 Lakh Vials Per Month

Swarajya Staff
4y Insta
image

Researchers Plan Clinical Trials Of Antiviral Drug For Cats That May Help Fight Covid-19 In Humans

IANS
4y News Brief
image

Get Swarajya in your inbox.


About Swarajya

Shaping the modern Indian's worldview, speaking on behalf of those invested in the cultural and economic prosperity of India. Published since 1956.


Swarajya is a publication by Kovai Media Private Limited.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.
    Artboard 2 Copy 10Created with Sketch.
    Artboard 2 Copy 7Created with Sketch.
    Artboard 2 Copy 9Created with Sketch.
  • Andriod Logo
  • IOS Logo